Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have been diagnosed with peripheral artery disease (PAD) — a condition where narrowed arteries reduce blood flow to the legs — and are experiencing symptoms such as leg pain when walking
- People whose ankle-brachial index (a blood pressure measurement comparing the ankle and arm) shows reduced blood flow, either at rest or after a walking test on a treadmill
- People with diabetes or kidney problems may qualify based on a different blood flow measurement called a toe-brachial index, if their arteries are too stiff for the standard test (confirm with trial site)
- People who have read, understood, and signed a consent form agreeing to take part in the trial
Who may not be able to join:
- People under 18 years of age
- People who are unable to walk on a treadmill at a gentle pace (3.2 km/h on a flat surface) for at least 300 metres
- People who have taken part in a supervised exercise training program within the last year
- People who have previously had an amputation of a leg or foot
- People who have a medical reason that means exercise is not safe for them
- People who have a neurological, neuromuscular, bone, or joint condition that affects the way they walk
- People who are known to be pregnant
- People who are not able to make their own informed decisions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximal walking distance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.